Tradestie Institutional Equity Comparison Engine

AYTU vs CRON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRON Overall Edge

CRON Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cronos Group Inc. Common Share (CRON) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AYTU counters with relative strength in Valuation. Fundamentally, AYTU trades at 9.2x Forward P/E with -14.4% operating margin (+6.4% YoY revenue) versus CRON at 13.3x Forward P/E and 6.1% operating margin (+74.6% YoY). In options structure, AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CRON sits in CONSOLIDATION (20th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
AYTU 9.2x vs CRON 13.3x Fwd P/E
Growth & Margin Winner CRON
Op Margin -14.4% vs 6.1% ยท YoY +6.4% vs +74.6%
Momentum & Technical Winner CRON
1Y -12.1% vs +31.6% ยท 52W Pos 5% vs 60%
Options & Structure Winner CRON
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (20th %ile IV)
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0
CRON NASDAQ
Cronos Group Inc. Common Share
Medicinal Chemicals & Botanical Products
$3.26
-3.48% 1D
Market Cap $1.2B
1M Return +1.63%
1Y Return +31.55%
Forward P/E 13.3x
Unified AI Score
53.9 / 100 HOLD
Tech 46.0 Fund 51.0 Flow 58.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AYTU -12.14% CRON +31.55% Spread: +43.69 pp (CRON Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AYTU Revenue CRON Revenue AYTU Op. Margin CRON Op. Margin Margin Edge
FY2019 $10M $20M -230.1% -645.5% AYTU
FY2020 $30M $50M -76.5% -469.6% AYTU
FY2021 $70M $60M -89.7% -452.2% AYTU
FY2022 $100M $90M -113.7% -128.4% AYTU
FY2023 $110M $90M -15.9% -97.2% AYTU
FY2024 $70M $120M -2.4% -65.1% AYTU
FY2025 $70M $150M -11.8% -11.9% AYTU
FY2026 $60M N/A -14.4% N/A AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AYTU (3) vs CRON (7)
Institutional Metric AYTU CRON Criterion Row Winner
Market Capitalization Scale $19.6M $1.2B Larger Scale CRON
Trailing P/E Ratio Valuation 9.2x 21.3x Lower Multiple AYTU
Forward P/E Ratio Valuation 9.2x 13.3x Lower Multiple AYTU
Revenue Growth (YoY) Growth +6.4% +74.6% Higher Growth CRON
Operating Margin (TTM) Profitability -14.4% 6.1% Higher Margin CRON
Net Profit Margin Profitability -24.8% 28.0% Higher Margin CRON
Return on Equity (ROE) Capital Efficiency -52.5% 6.1% Higher ROE CRON
52-Week Range Position Momentum 5% ($2โ€“$3) 60% ($2โ€“$4) Stronger Trend CRON
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 35% Vol 0.35ฮฒ ยท 40% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 53.9 / 100 (HOLD) Higher Composite CRON

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AYTU vs CRON Buy Guide
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRON CONSOLIDATION
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live CRON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AYTU nor CRON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.